Owned by the Association for International Promotion & Study in Tumors (APSIT)
Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
Melanoma is the most aggressive and deadly form of skin cancer with increasing case numbers worldwide. The development of inhibitors targeting mutated BRAF (found in around 60% of melanoma patients) has marked...